A 55p superfood drink could help fight the symptoms of Alzheimer’s disease, according to a new study. This beverage, which is ...

Daily consumption of 57g of pecans for 12 weeks improved cholesterol profiles and diet quality in adults at risk of ...

Inclusion of female and Hispanic/Latino patients has increased over time, but most trials of metabolic dysfunction-associated ...

Black patients show higher clinical trial interest with Black researchers. Learn how representation matters in medical ...

Research from the University of British Columbia reveals concerning patterns in how ADHD is portrayed on TikTok and how those ...

The phase 3 trial design evaluating IMNN-001 in newly diagnosed advanced ovarian cancer has been finalized among regulatory ...

Researchers conducted a randomized clinical trial examining the effects of semaglutide in non-treatment-seeking adults with alcohol-use disorder.

IMUNON (IMNN) announced that the U.S. Food and Drug Administration is aligned with the protocol for the Phase 3 pivotal trial, called OVATION ...

Additional alignment with FDA on LX2006 planned pivotal study including protein expression co-primary endpoint: based on improvements in LVMI ...

The phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary ...

Long-term adherence to the American Heart Association’s “Life’s Essential 8” lifestyle score significantly reduces the risk ...

The probiotic-rich drink kefir may be a potential complementary treatment for Alzheimer’s disease by helping improve ...